Fol. Biol. 2025, 71, 88-94
https://doi.org/10.14712/fb2025071020088
Semi-automated RNA Isolation from Tempus Blood RNA Tubes Using the Magcore Plus II Instrument
References
1. 2016) Translating RNA sequencing into clinical diagnostics: opportunities and challenges. Nat. Rev. Genet. 17, 257-271.
< , S. A., Van Keuren-Jensen, K. R., Engelthaler, D. M. et al. (https://doi.org/10.1038/nrg.2016.10>
2. 2016) Peripheral blood collection: the first step towards gene expression profiling. Biomarkers 21, 458-465.
< , C., Remy, S., Lambrechts, N. et al. (https://doi.org/10.3109/1354750X.2016.1153721>
3. 2014) Comparison of whole blood RNA preservation tubes and novel generation RNA extraction kits for analysis of mRNA and miRNA profiles. PLoS One 9, e113298.
< , M., Tolios, A., Beutner, F. et al. (https://doi.org/10.1371/journal.pone.0113298>
4. 2024) Diagnostic outcomes of concurrent DNA and RNA sequencing in individuals undergoing hereditary cancer testing. JAMA Oncol. 10, 212.
< , C., Hoang, L., Zimmermann, H. et al. (https://doi.org/10.1001/jamaoncol.2023.5586>
5. 2020) RNA-seq analysis is a useful tool in variant classification. JCO Precis. Oncol. 4, 1226-1227.
< , R., LaDuca, H., Richardson, M. E. et al. (https://doi.org/10.1200/PO.20.00310>
6. 2024) Parallel DNA/RNA NGS using an identical target enrichment panel in the analysis of hereditary cancer predisposition. Folia Biol. (Praha) 70, 62-73.
< , P., Černá, M., Zemánková, P. et al. (https://doi.org/10.14712/fb2024070010062>
7. 2019) Comparable type I interferon score determination from PAXgene and Tempus whole blood RNA collection and isolation systems. BMC Res. Notes 12, 511.
< , L., Niemietz, I., Brown, K. L. (https://doi.org/10.1186/s13104-019-4562-z>
8. 2008) Assessment of sample collection and storage methods for multicenter immunologic research in children. J. Immunol. Methods 339, 82-89.
< , L. A., Duong, T. T., Rosenberg, A. M. et al. (https://doi.org/10.1016/j.jim.2008.08.003>
9. 2019) Simultaneous extraction of mRNA and microRNA from whole blood stabilized in tempus tubes. BMC Res. Notes 12, 39.
< , J., Unger, E. R., Rajeevan, M. S. (https://doi.org/10.1186/s13104-019-4087-5>
10. 2018) Impact of RNA integrity and blood sample storage conditions on the gene expression analysis. Onco Targets Ther. 11, 3573-3581.
< , Y., Li, R., Tian, F. et al. (https://doi.org/10.2147/OTT.S158868>
11. 2022) Transcriptomics and solid tumors: the next frontier in precision cancer medicine. Semin. Cancer Biol. 84, 50-59.
< , A. M., Fountzilas, E., Bleris, L. et al. (https://doi.org/10.1016/j.semcancer.2020.09.007>
12. 2009) Methods of RNA purification. All ways (should) lead to Rome. Folia Biol. (Praha) 55, 243-251.
< , I., Vanícková, Z., Sedo, A. (https://doi.org/10.14712/fb2009055060243>
13. 2014) Assessment of magnetic bead-based automated whole blood RNA – isolation from a validated RNA stabilization reagent (Tempus Blood RNA). J. Immunol. Methods 406, 148-149.
< , S., Bleck, E., Brinks, R. et al. (https://doi.org/10.1016/j.jim.2014.02.015>
14. 2010) Assessment of mRNA and microRNA stabilization in peripheral human blood for multicenter studies and biobanks. Biomark. Insights 22, 95-102.
, D. G., Casjens, S., Rozynek, P. et al. (